Company
Headquarters: San Francisco, CA, United States
Founded: 2008
Employees: 440
CEO: Ms. Maeve O'Meara
$335.5 Million
USD as of Feb. 1, 2022
Company | Market Cap (USD) |
---|---|
GE HealthCare | $35.26 B |
Veeva Systems Inc. | $29.31 B |
Change Healthcare Inc. | $9.03 B |
Pro Medicus Limited | $8.96 B |
Signify Health, Inc. | $8.38 B |
Company | Market Cap (USD) |
---|---|
Lilly | $808.65 B |
Novo Nordisk | $622.07 B |
UnitedHealth Group | $450.89 B |
Johnson & Johnson | $350.63 B |
Merck | $318.75 B |
Castlight Health, Inc. provides health navigation solutions for employers and health plan customers in education, manufacturing, retail, government, and technology industries in the United States. It provides Care Guidance Navigator that enables users to make better care decisions and navigate the employer-sponsored healthcare benefit programs; Wellbeing Navigator, which helps to drive engagement across an employer's benefits program; Complete Health Navigator that combines the Wellbeing Navigator and Care Guidance Navigator packages for unified user experience; and Castlight Care Guides, a high-touch navigation service. The company also offers white-labeled health navigation solutions and embedded platform technology services. In addition, it provides implementation and marketplace services. The company was formerly known as Ventana Health Services and changed its name to Castlight Health, Inc. in April 2010. Castlight Health, Inc. was incorporated in 2008 and is headquartered in San Francisco, California. As of February 16, 2022, Castlight Health, Inc. operates as a subsidiary of Vera Whole Health Inc..
Top 1-year algo backtest: +265.99%
$10,000 in October 2023 would now be $36,599 by following this algorithm daily at market close.
Use AI to boost your investing & swing trading, now!
Try Disfold DeepFinance FREE
Castlight Health, Inc. has the following listings and related stock indices.
Stock: NYSE: CSLT wb_incandescent
Stock: FSX: 109 wb_incandescent
Maeve O' Meara, CEO Siobhan Nolan Mangini, President & Chief Financial Officer Giovanni Colella, M D Former CEO and Founder. John Doyle, Former CEO
Revenue: US$143 million (2019) US$156 million (2018)
Net income: US$ (58) million loss(2016)